CU6 — Clarity Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- AU$685.88m
- AU$647.90m
- 30
- 16
- 90
- 45
Annual balance sheet for Clarity Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 6.27 | 18.9 | 92.3 | 65 |
| Net Total Receivables | 2.66 | 3.37 | 6.66 | 10 |
| Prepaid Expenses | ||||
| Total Current Assets | 9.05 | 22.5 | 99.6 | 76.7 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0.05 | 0.093 | 0.26 | 0.206 |
| Long Term Investments | ||||
| Total Assets | 9.12 | 22.6 | 99.8 | 76.9 |
| Accounts Payable | ||||
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.947 | 2.25 | 7.51 | 7.54 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 0.956 | 2.34 | 7.59 | 7.72 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 8.16 | 20.3 | 92.2 | 69.2 |
| Total Liabilities & Shareholders' Equity | 9.12 | 22.6 | 99.8 | 76.9 |
| Total Common Shares Outstanding |